Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03421067 · ClinicalTrials.gov registry record
Apical Support During Hysterectomy for Pelvic Organ Prolapse-NSQIP Analysis.
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 3,458
- Enrollment target
NCT03421067: Completed study, sponsored by TriHealth.
NCT03421067 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 3,458 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03421067 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 3,458 participants
- Enrollment target
Study Summary
This is a retrospective descriptive study using the American College of Surgeon's National Surgical Quality Improvement Program® (ACS NSQIP®) data to determine whether gynecologic surgeons are already meeting the recently recommended best practice of supporting the vaginal apex at time of hysterectomy for pelvic organ prolapse (POP).
Primary Outcome
proportion of patients who had concurrent apical support procedures performed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,458 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2019-02-14 |
What the finished NCT03421067 record still lists
NCT03421067 is an observational study that tracks outcomes without assigning an intervention. Its 3,458 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03421067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03421067 about?
NCT03421067 is a clinical study titled "Apical Support During Hysterectomy for Pelvic Organ Prolapse-NSQIP Analysis.". This is a retrospective descriptive study using the American College of Surgeon's National Surgical Quality Improvement Program® (ACS NSQIP®) data to determine whether gynecologic surgeons are already meeting the recently recommended best practice of supporting the vaginal apex at time of hysterecto...
What is the current status of trial NCT03421067?
This trial is currently completed. The enrollment target is 3,458 participants. The study started on 2018-02-27. Estimated completion is 2019-02-14.
Who is sponsoring clinical trial NCT03421067?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI